https://www.selleckchem.com/pr....oducts/etomoxir-na-s
In angiogenesis experiments, the angiogenesis ability and the expressions of related proteins in ovarian cancer cell lines were down-regulated after ES treatment. Furthermore, ES reduced the expression of PD-L1 and suppressed the phosphorylation of STAT3 in ovarian cancer cell lines. ES blocked the metastasis, invasion and angiogenesis of ovarian cancer cells by suppressing the activation of PD-L1 and STAT3, which might be considered as the potential mechanism of ES in the treatment of ovarian cancer.Hepatocellular carcinoma (H
Like
Comment
Share
